Dr Richard Shaffer is a recognised Consultant Clinical Oncologist and a prominent UK expert in the use of radiotherapy for treating benign disease (including Dupuytren's disease, Ledderhose, plantar fasciitis and keloid scarring) and non-melanoma skin cancer.

Since starting his practice in 2011, Dr Shaffer has treated approximately 2000 non-cancer (benign) patients with radiotherapy, and provided training and mentoring to fellow consultants starting benign radiotherapy practices. He co-wrote the 2015 Royal College of Radiologists guidelines for radiotherapy for benign conditions and is the founder and President of the International Society for Radiotherapy for Benign Conditions.

He is UK Clinical Lead for Radiotherapy for benign conditions at GenesisCare and chairs the weekly UK skin and benign Multidisciplinary team meeting. He is also Medical Director of XStrahl Limited – a medical device company that makes superficial radiotherapy machines for the treatment of benign conditions and skin cancer.

He has previously been chair of the IMRT-IGRT Radiotherapy Group, the Network Brain Tumour Working Group, Clinical Lead for Radiotherapy at St Luke's Cancer Centre, and a trustee of the Fountain Centre (a local patient support charity).

In his early career, Dr Shaffer trained as a specialist registrar at various London teaching hospitals and completed a Clinical Fellowship in Radiation Oncology at the British Columbia Cancer Agency in Vancouver, Canada.

Clinical interests

• Dupuytren's disease
• Ledderhose disease
• Plantar fasciitis
• Achilles tendinopathy
• Keloid scarring
• Skin Cancer
• Prostate Cancer
• Bladder Cancer

• BSc (Hons) in Biomedical Science - first - Manchester University
• MBBS (primary medical qualification) - University of London 1998
• MRCP - Member of Royal College of Physicians
• FRCR - Fellow of Royal College of Radiologists (Clinical Oncology)
• Specialist Register for Clinical Oncology
• Member of the Royal College of Physicians and Fellow of the Royal College of Radiologists